Dr. Bayard Powell Discusses CPI-613 in Advanced Hematologic Malignancies

feeds has 409 videos Subscribe Here

Description: Bayard L. Powell, MD, the Director-At-Large and a Professor in Hematology & Oncology at the Wake Forest Baptist Medical Center Comprehensive Cancer Center, discusses a phase I study that explored the first-in-class mitochondrial metabolism inhibitor CPI-613 in patients with advanced hematologic malignancies.

To view more resources on hematologic malignancies, visit
Shared By : feeds
Posted on : 09/03/13
Added : 4 years ago


Nothing found.

More From feeds

Nothing found.